75 Participants Needed

Self-swab Testing for STDs

(STAMP Trial)

OH
Overseen ByOlivia H Manayan, MD, MPH
Age: Any Age
Sex: Female
Trial Phase: Academic
Sponsor: Queen's Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are:What is the acceptability, feasibility, and utilization of self-collected STI screening at the time of telemedicine medication abortion provision?How does the uptake of such a service among patients receiving telemedicine abortion care compare to the population of patients who seek in-person medication abortion care?What are the positivity rates for STIs in among patients receiving telemedicine medication abortion care compared to the positivity rates for a contemporaneous, in-clinic population?What is the average time to between testing and treatment for patients who test positive for an STI using the self-collection service?Researchers will compare the intervention group to a contemporaneous, in-clinic population on uptake of STI screening, as well as on positivity rates for the STIs tested.Participants will be asked to perform self-swab collection for STI testing for gonorrhea, chlamydia, and trichomonas. They will be instructed to send their specimens to a lab using prepaid postage. Upon completion of sample collection and shipping, they will be asked to complete a survey assessing basic demographic information, as well as acceptability and feasibility of the intervention. Patients who test positive for an STI will be promptly provided/referred to treatment.

Are You a Good Fit for This Trial?

This trial is for patients over age 14 at the Queen Medical Center Options Clinic seeking a medication abortion via telemedicine, who either meet CDC guidelines for STI testing or want screening. Participants must speak and read English and be able to give informed consent.

Inclusion Criteria

I am 14 years old or older.
I can speak and read English.
I am a patient at the Queen Medical Center Options Center seeking a telemedicine medication abortion.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (virtual)

Intervention

Participants perform self-swab collection for STI testing and send specimens to the lab

Up to 1 week
1 visit (virtual)

Follow-up

Participants are monitored for test results and provided treatment if STI positive

1-2 weeks
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas
Trial Overview The study tests the acceptability and feasibility of self-swab STI testing (for chlamydia, gonorrhea, trichomonas) offered alongside telemedication abortion services. It compares this group's uptake and positivity rates with those receiving in-person care.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Self-swab ArmExperimental Treatment1 Intervention
Group II: in-clinic STI testing armActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Queen's Medical Center

Lead Sponsor

Trials
24
Recruited
4,900+

University of Hawaii Foundation

Collaborator

Trials
2
Recruited
60+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security